o2h ventures has announced the launch of its HMRC approved knowledge intensive EIS fund, focusing on supporting the expansion of UK research and development in biotech therapeutics and AI.

To support the Government’s aim to strengthen and grow UK innovation, which were known to be capital and research intensive, the EIS knowledge intensive fund has been launched to pledge support to companies working in this space, providing them access to capital to develop their early novel ideas.

Knowledge intensive investing offers investors an opportunity to take advantage of the predictability of the tax year, from which they are able to claim relief. To date, investors in Enterprise Investment Scheme (EIS) funds claim relief when the funds are deployed into a business. However, in the new HMRC approved knowledge intensive funds, relief is dated when the investment into the fund is made (with carry back options depending on individual circumstances).

o2h ventures is in an exciting position to meet the criteria for knowledge intensive investing to nurture early stage biotech therapeutics & AI assets through seed investment, working alongside and investing in companies that can look to generate returns (financial, social and ethical) for investors as part of the post seed and early finance cycle.

Click here to read the full article.



020 7071 3945


Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.